1. C-X-C-Chemokine-Receptor-Type-4 Inhibitor AMD3100 Attenuates Pulmonary Inflammation and Fibrosis in Silicotic Mice
   Qixian Sun et al, 2022, Journal of Inflammation Research CrossRef
2. Identification of Impacted Pathways and Transcriptomic Markers as Potential Mediators of Pulmonary Fibrosis in Transgenic Mice Expressing Human IGFBP5
   Xinh-Xinh Nguyen et al, 2021, International Journal of Molecular Sciences CrossRef
3. Immune and Metabolic Alterations in Liver Fibrosis: A Disruption of Oxygen Homeostasis?
   Xinyu Li et al, 2022, Frontiers in Molecular Biosciences CrossRef
4. Nintedanib downregulates the transition of cultured systemic sclerosis fibrocytes into myofibroblasts and their pro-fibrotic activity
   Maurizio Cutolo et al, 2021, Arthritis Research & Therapy CrossRef
5. CXC Chemokines in the Pathogenesis of Pulmonary Disease and Pharmacological Relevance
   Kayode Komolafe et al, 2022, International Journal of Inflammation CrossRef
6. Network Pharmacology Analysis of the Therapeutic Potential of Colchicine in Acute Lung Injury
   Fei Sun et al, 2024, International Journal of Clinical Practice CrossRef
7. Hallmarks of aging-based dual-purpose disease and age-associated targets predicted using PandaOmics AI-powered discovery engine
   Frank W. Pun et al, 2022, Aging CrossRef
8. Human Cytomegalovirus and Human Herpesvirus 6 Coinfection of Dermal Fibroblasts Enhances the Pro-Inflammatory Pathway Predisposing to Fibrosis: The Possible Impact on Systemic Sclerosis
   Irene Soffritti et al, 2022, Microorganisms CrossRef
9. Pericytes: The lung-forgotten cell type
   Annelise T. Garrison et al, 2023, Frontiers in Physiology CrossRef